Q2/2024: Monthly: Biohaven Pharmaceutical Holding (BHVN: $34.71) in bottom 3% performers of NYSE market in past quarter

Press/Media

Period28 Jun 2024

Media coverage

1

Media coverage

  • TitleQ2/2024: Monthly: Biohaven Pharmaceutical Holding (BHVN: $34.71) in bottom 3% performers of NYSE market in past quarter
    Media name/outletGlobal Round Up - Bullish & Bearish Signals
    Country/TerritoryUnited States
    Date28/06/24
    PersonsMichael Thomas
View all 1
View less